Literature DB >> 9359830

Cloning and overexpression of rat kidney biliverdin IX alpha reductase as a fusion protein with glutathione S-transferase: stereochemistry of NADH oxidation and evidence that the presence of the glutathione S-transferase domain does not effect BVR-A activity.

O Ennis1, R Maytum, T J Mantle.   

Abstract

Native biliverdin IX alpha reductase (BVR-A) is a monomer of molecular mass 34 kDa. We have developed an expression vector that allows the isolation of 40 mg of a glutathione S-transferase (GST)-BVR-A fusion protein from 1 litre of culture. The fusion protein (60 kDa) behaves as a dimer on gel filtration (120 kDa), so that we have artificially created a BVR-A dimer. The recombinant rat kidney enzyme exhibits pre-steady-state 'burst' kinetics that show a pH dependence similar to that already described for ox kidney BVR-A. Similar behaviour was obtained in the presence and absence of the GST domain both for the burst kinetics and during initial-rate studies in the presence and absence of albumin. The stereospecificity of the BVR-A-catalysed oxidation of [4-3H]NADH, labelled at the A and B faces, was shown to occur exclusively via the B face.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359830      PMCID: PMC1218883          DOI: 10.1042/bj3280033

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees.

Authors:  S C Hunt; L L Wu; P N Hopkins; R R Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-08       Impact factor: 8.311

2.  Regulation of hepatic haem metabolism. Disparate mechanisms of induction of haem oxygenase by drugs and metals.

Authors:  B C Lincoln; J F Healey; H L Bonkovsky
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

Review 3.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

4.  A candidate reference method for determination of bilirubin in serum. Test for transferability.

Authors:  B W Perry; B T Doumas; D D Bayse; T Butler; A Cohen; W Fellows; C C Garber; B Howell; T Koch; S Krishnamurthy; A Louderback; R B McComb; D Miller; R R Miller; R N Rand; R Schaffer
Journal:  Clin Chem       Date:  1983-02       Impact factor: 8.327

5.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

6.  On the possible role of biliverdin stimulation of cyclic AMP levels as a trigger for liver regeneration in the rat.

Authors:  O Phillips; T J Mantle; A R Tuffery; C M Heyworth; S R Wilson; M D Houslay
Journal:  Biochem Pharmacol       Date:  1984-06-15       Impact factor: 5.858

7.  Antioxidant activity of albumin-bound bilirubin.

Authors:  R Stocker; A N Glazer; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Studies of bilirubin kinetics in normal adults.

Authors:  P D Berk; R B Howe; J R Bloomer; N I Berlin
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

Review 9.  Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications.

Authors:  M D Maines
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

10.  Heme oxygenase: a novel target for the modulation of the inflammatory response.

Authors:  D Willis; A R Moore; R Frederick; D A Willoughby
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

View more
  1 in total

1.  Activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions.

Authors:  Edward Franklin; Seamus Browne; Jerrard Hayes; Coilin Boland; Aisling Dunne; Gordon Elliot; Timothy J Mantle
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.